Tag: False Claims Act

History is History – Qui Tam Provisions No FCA Mystery

Judge Kenney of the Eastern District of Pennsylvania, in Jonathan Meyer v ADS Clinics, LLC, No. 21-cv-5303, on February 10, 2026, rejected a most recent attempt to gut the qui tam provisions from the federal False Claims Act (FCA) based on the Appointments, Vesting and Take Care Clauses of Article II of the United States Constitution.

Is Finality Still Useful in False Claims Act Litigation?

All of us were treated recently to the latest statistics from the Department of Justice for 2025.  By all accounts it was a record year for both the Department of Justice and relators, over $6.8 billion in total recoveries, including some impressive resolutions obtained in non-intervened cases. By my count,

Laboratory Fraud: The Gift That Keeps On Giving

Takeaway: Laboratory fraud continues to be pervasive in the healthcare industry.

Every sector of the healthcare industry relies upon laboratory testing. Lab tests are used to diagnose virtually all illnesses and conditions ranging from the common flu to cancer. The average American receives their first lab test, in the form of genetic testing,

Governor Shapiro Uses his Annual Budget Address to Call for Pennsylvania to Finally Pass a State False Claims Act

In a move to fortify the Pennsylvania treasury’s defenses against fraud, Governor Josh Shapiro utilized his 2026-2027 Budget Address earlier today to call for the creation of a Pennsylvania state False Claims Act (“FCA”).  Federal and state FCAs allow the government to seek enhanced damages against fraudsters and offer whistleblowers awards for exposing fraud against the government.

DOJ Announces the Largest Customs Fraud Settlement in False Claims Act History

Takeaway: The Department of Justice (“DOJ”) continues to take customs fraud seriously. With the Department of Justice’s newly launched Trade Fraud Task Force, the government has signaled a zero-tolerance policy for customs evasion—particularly regarding Chinese goods.  DOJ’s recent $54.4 million settlement with Ceratizit, the largest customs fraud settlement in False Claims Act history,

Recent False Claims Act Settlement Should Put Treatment Centers on Notice

Late last month, the federal government announced a False Claims Act settlement with Summit BHC New Jersey, LLC, d/b/a Seabrook (“Seabrook”), a prominent New Jersey Drug & Alcohol Rehabilitation facility. The joint settlement with the New Jersey Attorney General’s Office, in the amount of $19,751,762.69, covered claims submitted by Seabrook under the Medicaid program and Department of Veterans Affairs benefit programs.

Hidden Dangers Lurking in Corporate Integrity Agreements

When I litigated False Claims Act (FCA) cases at the U.S. Department of Justice (DOJ), it was common practice for settlements to require Corporate Integrity Agreements (CIAs) setting forth ongoing duties and responsibilities for corporate defendants entering a settlement with the DOJ.  Sometimes, those CIAs included stipulated penalty provisions, which establish set penalty amounts for violations of the terms of the CIA. 

Will Whistleblowers Opportunities Rise If/When the Special Inspector General for Pandemic Recovery “Sunsets?”

Without Congressional action, the authority of the Special Inspector General for Pandemic Recovery (SIGPR) will sunset on March 27, 2025. The Coronavirus Aid, Relief, and Economic Security (CARES) Act was enacted in March 2020 to provide emergency financial assistance to millions of Americans suffering the economic effects of the COVID-19 pandemic.

Contact one of our

Experienced Attorneys

If you are aware of any person, corporation or entity that you think may be violating the Federal False Claims Act or a State False Claims Act, contact us today.

CONTACT US